<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b30/5341949/2beeebf977cf/oncotarget-07-72860-g001.jpg"/> </div> <div class="text-side"> <h1>Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.</h1> <p>NY-ESO-1 immunohistochemical staining pattern and intensity in liposarcomas and MPNSTPrimary myxoid/round cell liposarcoma, H&amp;E (A) and diffuse (&gt; 75% of cells staining) 3+ IHC positivity (B). Dedifferentiated liposarcoma, H&amp;E (C) and 3+ IHC positivity in &gt; 25% of cells (D). MPNST, H&amp;E (E) and diffuse 3+ IHC positivity (F). Metastatic mxyoid/round cell liposarcoma, H&amp;E (G) and diffuse 3+ IHC positivity (H). (200Ã— magnification).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27655679/" target="_blank">27655679</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>